• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Sumitomo Pharma, suffering from sliding sales, lays off another 400 US staffers

cafead

Administrator
Staff member
  • cafead   Mar 05, 2024 at 10:33: PM
via Sumitomo Pharma’s hundeds of layoffs last summer weren't enough for the struggling company to stem the tide as its revenues decline and its bond prices crater.

Now, the Japanese drugmaker is letting go of 400 staffers this month.

article source